To investigate the effect of gender on catecholamine responses to hypoglycaemia, single-step euglycaemichypoglycaemic clamps have been performed in 14 healthy men and 17 women. Adrenaline responses were 44 % lower in females (p<0.01) and noradrenaline 17% lower (p = 0.08). In response to low-dose intravenous insulin infusion (0.3 mU. kg-1. min-1), plasma glucose fall and counterregulation in seven men and seven women had a different course (p < 0.001), with different glucose kinetics. In men, endogenous glucose output recovered quickly to levels that exceeded basal; in women suppression of endogenous glucose output was more prolonged, without rates ever exceeding basal (p < 0.05). Peripheral glucose uptake was stimulated in men only. The hormones of acute glucose counterregulation (catecholamines and glucagon) did not differ between the sexes during this challenge, the catecholamine response in the women being supported by the continuous fall in plasma glucose. These results suggest that: 1) catecholamine responses to moderately controlled hypoglycaemia are diminished in women, and 2) peripheral insulin sensitivity in men is enhanced over that of women but hepatic sensitivity to insulin may be greater in women.
During prolonged fasting, women achieve lower blood glucose levels than do men [1] . Yet differences in responses to acute hypoglycaemia have not been investigated and studies into the physiology and pathophysiology of counterregulation to hypoglycaemia commonly include men and women in a single group. The present investigations were designed to investigate responses to hypoglycaemia in men and women separately. We chose to use the euglycaemic-hypoglycaemic insulin clamp [2] , in order to measure catecholamine responses to a single reproducible hypoglycaemic stimulus in healthy men and women and a low-dose insulin infusion (without exogenous glucose infusion) in order to examine overall ability spontaneously to counterregulate [3] . Stable isotopes have been used to examine glucose kinetics in the latter study.
Subjects, materials and methods
Forty-five age-matched healthy men and women were recruited for study. All subjects were consuming a weight-maintaining diet. None of the subjects was an athlete and none had a family history of diabetes mellitus. Subjects were asked to refrain from alcohol for 24 h and from smoking for 12 h before study. Each subject performed one study only.
Subjects were admitted to the research units in the morning after an overnight fast. Two intravenous cannulae were inserted using intradermal lignocaine as a local anaesthetic. One cannula, for infusion of test substances, was inserted into an antecubital vein, the second, for the sampling of arterialised venous blood, was placed retrograde into a dorsal vein of a hand placed in a box of air heated to 55-60~ [4] . All subjects rested for at least 30 min after the insertion of intravenous lines before baseline blood sampling. All studies were conducted with the subjects supine or semi-recumbent.
Subjects gave written informed consent prior to each study. All protocols were approved either by the ethical committee of the University of Nottingham Medical School, or by the Lewisham and North Southwark Committee of Ethical Practice, London, and studies were conducted in accordance with the Helsinki Declaration.
Study one: euglycaemic-hypoglycaemic insulin clamp: (14 men, aged 20 to 34 years, BMI 20-26.6 kg/m 2 and 17 women, aged between 22 and 33 years with BMI ranging from 21 to 27 kg/m2).
A primed continuous infusion of human insulin (human Actrapid; Novo-Nordisk, Copenhagen, Denmark, made up in a 4 % solution of the subject's blood in 0.9% NaC1) was begun at a maintenance rate of 60 mU/m z per rain. Blood glucose was maintained at euglycaemic levels for 30 rain by means of a variable rate glucose infusion. The blood glucose was then allowed to fall to 2.5 retool/1 where it was held by further adjustment of the glucose infusion for 30 rain. Blood glucose was measured every 10 min and additional samples for later measurement of catecholamine levels were taken at baseline, at 30 rain and at 60 min. and 45 years, BMI 20.9 to 25.1 kg/m 2 and seven women aged 25 to 36 years (p = 0.59), BM120.1 to 24.3 kg/m 2 (p = 0.53). Women on the contraceptive pill were excluded from study.
A primed (100:1) continuous infusion of [6-62H]2 glucose (Tracer Technologies, Somerville, Mass., USA) was started and run at 0.0375 mg. kg-1-min-1 for 120 man. During this time, measurement of the four-choice reaction time (a test of psychomotor performance in which the subject has repeatedly to clear a computer generated signal from a quadrant of the computer screen by depressing the corresponding button on the key pad) was made at least four times, until reproducible test results were obtained. Performance on this test tends to improve in terms of speed and accuracy of response after the first attempt but after three to five measurements remains stable. Baseline blood samples were taken over 30 rain to ensure plasma glucose tracer enrichment had reached steady state. Thereafter, a 3-h infusion of rapid acting human insulin (human Actrapid; Novo-Nordisk, Copenhagen, Denmark) was started at 0.6 mU-kg-z. min -1 for 5 min, followed by 0.3 mU. kg -1. min-~ for 175 min. Blood glucose was monitored every 5 min for the first hour and every 10 man thereafter. Additional blood samples were taken for later measurement of catecholamines, glucagon, growth hormone, cortisol, insulin and C-peptide. The study was stopped (and exogenous glucose given) if blood glucose fell below 2.6 mmol/1 for more than 10 min and the subject was either excessively uncomfortable or drowsy. At regular intervals throughout the study, subjects were asked to complete a symptom questionnaire (12 symptoms related to hypoglycaemia which were to be ranked on a linear analogue scale from 0 = none, to 6 = very severe) and four-choice reaction time was measured.
Measurements and calculations
During clamps and insulin infusions blood glucose was measured at the bedside using a glucose oxidase method (Yellow Springs Glucose Analyser; Yellow Springs Instrument Corporation, Yellow Springs, Ohio, USA). For measurement of glucose kinetics during the insulin infusion study, plasma was separated as soon as possible, frozen and stored at -70~ until enrichment of plasma glucose by tracer could be measured by gas chromatograph mass spectroscopy [5] . This was performed on a V. G. Trio-2 580 (Hewlett Packard, Woking, Surrey, UK) using selected ion monitoring of a glucose acetate boronate derivative [6] . The ions monitored were of molecular mass 297 (representing M-C4H9 + ) and 299 (the corresponding fragment enriched with two deuterium atoms). The intra-assay coefficient of variation of the measurement of isotope enrichment was less than 2 %. Glucose was measured as above in each plasma sample. Catecholamines were measured using HPLC [7] ; cortisol, glucagon, growth hormone and C-peptide and free insulin using radioimmunoassays [8] . Intra-assay variation was not greater than 9 % for any assay.
Symptom scores were expressed as the increase over the baseline score for autonomic symptoms (sweating, feeling nervous, heart pounding, trembling or shaking, tingling), for neuroglycopenic symptoms (difficulty in thinking, blurred vision, dizziness, tiredness, faintness) and for hunger [9] .
For analysis of the four-choice reaction time, both deterioration in speed (expressed as a 5 % increase in the mean time for a correct response) and accuracy (expressed as a 2 % reduction in the proportion of responses that were correct) were calculated.
Glucose kinetics have been analysed using modifications [5] of the non-steady-state adaptation [10] of Steele's equation [11] .
Statistical analysis
Demographic data are given as ranges. All results are given as the mean + SEM. The peak catecholamine responses to the damped hypoglycaemic stimulus of Study one have been compared by unpaired Student's t-tests. The effect of gender on the responses to the low-461 dose insulin of Study two has been analysed using a multivariate analysis of variance for repeated measures (MANOVA), with unpaired Student's t-testing on log-transformed data to ascertain significance of differences between the peaks of responses. Paired Student's t-testing has been used to establish the time point at which a significant difference over basal values occurred. Analyses were made using SSPS and t-testing was done using Minitab. P values of less than 0.05 were considered significant.
Results

Study one: catecholamine responses to a fixed hypoglycaemic stimulus
During the clamps, blood glucose fell from baseline over 30 min and was maintained at 2.5 mmol/1 for the final 30 min of each study (coefficient of variation range 1.5-5 %), with no significant differences between the stimulus in men or women ( 
Study two: glucose kinetics and counterregulation during insulin infusion
Basal plasma insulin levels were 8+1 mU/1 in men, 6+lmU/ml in women (p =0.5) and rose to steadystate levels of 18 + 1 mUd and 16_+ 1 mU/1, respectively ,p = 0.16). C-peptide fell progressively from 0.42 + The study in one subject (male), was stopped at 150 rain, despite stability of plasma glucose, because of severe symptoms. The plasma glucose responses to the mild peripheral hyperinsulinaemia (Fig.2, top panel) were significantly different (MANOVA F3.72, p < 0.001). Plasma glucose fell in both groups during the initial 40 min, but in the men there was an initial rapid fall, followed by stabilisation after 30 min, whereas in women a slow decline continued. Suppression of endogenous glucose production (Ra, Fig. 2 , middle panel) was more prolonged in the women (MANOVA sex alone F6.09, p = 0.03, sex by time F1.67, p < 0.05). In men, there was a rapid recovery of endogenous glucose output which was restored to basal values by 30 min (cf. 60 min in women) and then rebounded to values in excess of basal by 50min (2.64+0.23 vs 1.99 + 0.12 mg/kg per min,p = 0.03) which did not occur in women. Peripheral glucose uptake (Fig. 2, lower panel) was stimulated only in men (F1.73, p < 0.03), and occurred by 30 min. In contrast, there was no stimulation of peripheral glucose uptake in women.
The responses of the hormones of acute counterregulation (adrenafine, noradrenaline and glucagon, Fig. 3) were not significantly different overall, although the adrenaline response (Fig. 3, upper panel) of the men was more brisk and at 60 min exceeded that of the women (p < 0.03). The overall growth hormone response of men and women were not different although a peak response at 120 min was higher in women (p = 0.01).
Adrenergic symptom scores increased by 2 to 7 points in four women and by 2 to 4 points in four men; neuroglycopenie scores increased by between 2 and 5 points in four women and in three men. MANOVA showed no significant differences in these responses between the two sexes. Hunger, analysed separately occurred in all but one (male) subject, with an increase over baseline of 1 to 3 points in the men and 1 to 4 points in the women. This re-sponse was slightly greater in the men (MANOVA sex by time F2.55,p = 0.01). Deterioration in performance of the four-choice reaction time, defined as a 5 % or more increase in the mean correct time or a decrease in correct responses of 2 % or more, or both, occurred in all subjects, at a plasma glucose of 3.8 +0.3 mmol/1 in men and 3.7 + 0.1 mmol/1 in the women (p = 0.8). In many cases the deterioration was transient, with recovery to baseline in four of the women and five of the men.
Discussion
The well-described ability of healthy women to achieve and sustain greater degrees of hypoglycaemia during prolonged fasting [1] has not previously been examined. Indeed, male and female subjects are commonly mixed in investigations of responses to hypoglycaemia. Our data suggest, however, that there are important differences between healthy men and women in their responses to exogenous insulin, in their responses to hypoglycaemia and in their ability to counterregulate.
We have documented that healthy women show a greatly diminished adrenaline response to moderately controlled hypoglycaemia during hyperinsulinaemia. This finding is in agreement with preliminary reports from the laboratories of other investigators, also using an insulin clamp technique to apply a reproducible hypoglycaemic stimulus to all subjects [12, 13] . One of those reports suggests that the greater catecholamine responses in men to a fixed degree of moderate hypoglycaemia is due to triggering of the responses at higher glucose levels than in women, who sustain greater degrees of hypoglycaemia without response [13] . It is possible that responses to more profound degrees of hypoglycaemia eliminate this difference between men and women and that the use of the moderate stimulus of blood glucose damped at 2.5 mmol/1 allowed the difference to be detected.
The clamp technique is popular in the investigation of responses to hypoglycaemia because it ensures that the hypoglycaemic stimulus is always the same. However, precisely because the investigator has control over the degree of glucose fall, the overall ability of the subject to counterregulate cannot be measured. To investigate the physiological relevance of the gender differences in catecholamine response to hypoglycaemia, we examined the effect of low-dose insulin infusion in healthy men and women.
In men, the low-dose insulin infusion initially supressed endogenous (primarily hepatic) glucose production and stimulated peripheral glucose uptake, with a brisk fall in plasma glucose. The initial fall was secondary to the shut down of hepatic glucose output with peripheral glucose uptake rate also falling initially in response to the lower plasma glucose. Counterregulation occurred as a result of vigorous restimulation of the liver as well as a gradual reduction in peripheral glucose uptake. In women, only the hepatic effects of insulin were noted and recovery of hepatic glucose production was less vigorous. In the face of similar hormonal responses, these results suggest that peripheral insulin sensitivity in men is greater than that in women (perhaps because of their lower fat: muscle ratio, [14] ), but hepatic insulin sensitivity may be greater in women. A differential response of pancreatic insulin or glucagon, or both, cannot be ruled out by these studies.
In both sexes, recovery of hepatic glucose output preceded any change in circulating hormones, suggesting a greater effect of autoregulation than is usually believed to be the case, although an intraportal rise of glucagon cannot be excluded. Furthermore, the fall in C-peptide which occurred in both sexes reflects a counterregulatory reduction in pancreatic insulin, so that portal insulin levels may have fallen during the hypoglycaemia. In this case, the initial suppression of the liver either preceded any fall in pancreatic insulin and was a result of a net increase in portal levels or was a response to hyperinsulinaemia in the hepatic artery.
Unlike the recovery of endogenous glucose production, the eventual fall in peripheral glucose uptake seen in the men began after the adrenaline rise and may have been a response to autonomic stimulation.
In the clamp studies, when the degree of hypoglycaemia was perfectly matched women showed a markedly smaller catecholamine response than men. In the lowdose insulin infusion however, acute hormonal responses did not differ significantly between the sexes, despite the similarity of glucose nadir. This suggests that the catecholamine response in the women during low-dose insulin infusion was enhanced by the altered shape of the glucose curve, providing a more prolonged stimulus than in the men. This interpretation is supported by the earlier response of adrenaline in the men, with the higher peak at 60 min. Alternatively, hypoglycaemia induced by unopposed insulin infusion may provide a more powerful stimulus to counterregulation than hypoglycaemia induced by a clamp technique (during which exogenous glucose is administered), inducing a maximal catecholamine response and overcoming relatively subtle gender differences, as discussed above. Finally, it is possible that the catecholamine response is in fact controlled by the change in glucose kinetics, and in particular by the suppression of hepatic glucose production.
The apparen t discrepancy between the catecholamine responses to the two protocols illustrates the difficulties of usfilg uncontrolled hypoglycaemic stimuli to compare responses to hypoglycaemia between individuals. The technique of unopposed insulin administration permits assessment of overall counterregulatory ability. Only when such studies are combined with clamp techniques however can one begin to draw conclusions about components of the overall response.
The prevalence of symptoms of hypoglycaemia in the face of so mild a hypoglycaemic challenge in the low-dose insulin infusion is striking. The glucose levels associated with the symptoms were higher than in previous studies [15] [16] [17] but it is possible that the subjective response is diminished in studies using hypoglycaemia controlled by glucose infusion during higher dose insulin infusion. It should be noted that the formal documenting of symptoms does detect quite small subjective changes.
In conclusion, the present work has demonstrated differences in response to hypoglycaemia and insulin infusion between the sexes. Gender related differences in counterregulation and in hormonal responses to hypoglycaemia should preclude the mixing of the sexes in. unpaired studies of glucoregulation.
